Medicare Enrolled

Dr. Charukesi Chandrasekaran, MD

Psychiatry · Beaumont, TX
Low-engagement
4450 HIGHLAND AVE, Beaumont, TX 77705
7133517360
In practice since 2010 (15 years)
NPI: 1508173170 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chandrasekaran from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chandrasekaran? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chandrasekaran

Dr. Charukesi Chandrasekaran is a psychiatry in Beaumont, TX, with 15 years in practice.

Between the years covered by Open Payments, Dr. Chandrasekaran received a total of $6,162 from 36 pharmaceutical and/or device companies across 382 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chandrasekaran is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice$ $6,162 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$6,162
Total received (2019-2024)
Avg $1,027/year across 6 years
Top 11% in TX for psychiatry
36
Companies
382
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,162 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,182
2023
$1,734
2022
$1,144
2021
$742
2020
$105
2019
$255

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$701
AbbVie Inc.
$571
Corium, LLC
$430
Otsuka America Pharmaceutical, Inc.
$403
ITI, Inc.
$387
Lundbeck LLC
$351
Sunovion Pharmaceuticals Inc.
$320
Alkermes, Inc.
$271
Janssen Pharmaceuticals, Inc
$255
Takeda Pharmaceuticals U.S.A., Inc.
$234
Neurocrine Biosciences, Inc.
$224
Neos Therapeutics, LP
$216
Supernus Pharmaceuticals, Inc.
$199
Brainsway USA INC
$167
Ironshore Pharmaceuticals Inc.
$166
Boston Scientific Corporation
$158
Almatica Pharma LLC
$134
Merck Sharp & Dohme LLC
$120
Tris Pharma Inc
$113
Allergan Inc.
$89
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$89
IDORSIA PHARMACEUTICALS US INC
$81
Noven Therapeutics, LLC
$67
Allergan, Inc.
$67
JAZZ PHARMACEUTICALS INC.
$56
Bausch Health US, LLC
$48
IRONSHORE PHARMACEUTICALS INC.
$44
Merck Sharp & Dohme Corporation
$42
Axsome Therapeutics, Inc.
$27
Neuronetics, Inc.
$22
GRT US Holding, Inc.
$22
E.R. Squibb & Sons, L.L.C.
$21
Sage Therapeutics, Inc.
$21
Teva Pharmaceuticals USA, Inc.
$20
Adlon Therapeutics L.P.
$15
Vertical Pharmaceuticals, LLC
$12
Top 3 companies account for 27.6% of total payments
Associated products mentioned in payments ›
ABILIFY MYCITE · ADHANSIA XR · APLENZIN · ARISTADA · Adzenys XR-ODT · Austedo XR · Auvelity · Azstarys · BELSOMRA · BOTOX · Brainsway Deep TMS System · CAPLYTA · CITALOPRAM · COBENFY · COTEMPLA XR-ODT · Cotempla XR-ODT · Dyanavel XR · INGREZZA · INVEGA SUSTENNA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LOREEV XR · LYBALVI · NEUROSTAR TMS THERAPY · QELBREE · QUVIVIQ · Qelbree · Qutenza · RELEXXII · REXULTI · SERTRALINE HCL · SPRAVATO · SUNOSI · Secuado · TRINTELLIX · Trintellix · UBRELVY · VIVITROL · VRAYLAR · Vivitrol · Xelstrym · ZURZUVAE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a psychiatry in Beaumont?
Compare psychiatrys in the Beaumont area by procedure volume, costs, and industry payment transparency.
Browse psychiatrys nearby

Geographic Context

Psychiatrys within 10 mi
17
Per 100K population
6.7
County median income
$59,934
Nearest hospital
BAPTIST BEAUMONT HOSPITAL
12.1 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment✓ PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Chandrasekaran is a psychiatry, and high industry engagement (low-engagement, top 11%), with 15 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Chandrasekaran receive payments from pharmaceutical companies?
Yes. Dr. Chandrasekaran received a total of $6,162 from 36 companies across 382 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Chandrasekaran) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Psychiatrys in Beaumont
Browse psychiatrys in Beaumont ranked by procedure volume and transparency data.
Highest volume
Top Psychiatrys in TX
Psychiatrys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Psychiatrys in TX
Which TX psychiatrys receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC..
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc..
By company
Corium, LLC Payments to Doctors
See all physicians who received payments from Corium, LLC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →